2o2m
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2o2m.gif|left|200px]] | [[Image:2o2m.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2o2m", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | + | --> | |
| - | + | {{STRUCTURE_2o2m| PDB=2o2m | SCENE= }} | |
| - | + | ||
| - | | | + | |
| - | }} | + | |
'''Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand''' | '''Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand''' | ||
| Line 47: | Line 44: | ||
[[Category: Wendt, M D.]] | [[Category: Wendt, M D.]] | ||
[[Category: Zhang, H.]] | [[Category: Zhang, H.]] | ||
| - | [[Category: | + | [[Category: Apoptosis]] |
| - | [[Category: | + | [[Category: Bcl]] |
| - | [[Category: | + | [[Category: Complex]] |
| - | [[Category: | + | [[Category: Nmr]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 10:14:35 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 07:14, 4 May 2008
Solution structure of the anti-apoptotic protein Bcl-xL in complex with an acyl-sulfonamide-based ligand
Overview
Overexpression of the antiapototic proteins Bcl-2 and Bcl-xL provides a common mechanism through which cancer cells gain a survival advantage and become resistant to conventional chemotherapy. Inhibition of these prosurvival proteins is an attractive strategy for cancer therapy. We recently described the discovery of a selective Bcl-xL antagonist that potentiates the antitumor activity of chemotherapy and radiation. Here we describe the use of structure-guided design to exploit a deep hydrophobic binding pocket on the surface of these proteins to develop the first dual, subnanomolar inhibitors of Bcl-xL and Bcl-2. This study culminated in the identification of 2, which exhibited EC50 values of 8 nM and 30 nM in Bcl-2 and Bcl-xL dependent cells, respectively. Compound 2 demonstrated single agent efficacy against human follicular lymphoma cell lines that overexpress Bcl-2, and efficacy in a murine xenograft model of lymphoma when given both as a single agent and in combination with etoposide.
About this Structure
2O2M is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL., Bruncko M, Oost TK, Belli BA, Ding H, Joseph MK, Kunzer A, Martineau D, McClellan WJ, Mitten M, Ng SC, Nimmer PM, Oltersdorf T, Park CM, Petros AM, Shoemaker AR, Song X, Wang X, Wendt MD, Zhang H, Fesik SW, Rosenberg SH, Elmore SW, J Med Chem. 2007 Feb 22;50(4):641-62. Epub 2007 Jan 26. PMID:17256834 Page seeded by OCA on Sun May 4 10:14:35 2008
Categories: Homo sapiens | Single protein | Belli, B A. | Bruncko, M. | Ding, H. | Elmore, S W. | Fesik, S W. | Joseph, M K. | Kunzer, A. | Martineau, D. | McClellan, W J. | Mitten, M. | Ng, S C. | Nimmer, P M. | Oltersdorf, T. | Oost, T K. | Park, C M. | Petros, A M. | Rosenberg, S H. | Shoemaker, A R. | Song, X. | Wang, X. | Wendt, M D. | Zhang, H. | Apoptosis | Bcl | Complex | Nmr
